Choosing Among GLP-1 RAs
Choosing Among GLP-1 Receptor Agonists for Patients With Type 2 Diabetes

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Nurses: 0.25 Nursing contact hour

Released: February 26, 2023

Expiration: February 25, 2025

Instructions

This Interactive Decision Support Tool provides expert recommendations in selecting among the various GLP-1 RAs for patients with T2D based on the specific patient characteristics you enter. It is recommended that you have as much information as possible available before you begin.

You will be prompted to provide specific information about the patient such as

  • Cardiovascular disease
  • Renal function
  • A1C level
  • Retinopathy
  • Need for weight loss

Click on your selections. Your choices can be changed at any time simply by reviewing your saved answers, clicking on the [Change] link by your current answer, and selecting a new choice.

Additional information on each variable/characteristic and why it is important for making management selections is available by clicking on the [i] icon after each selection.

When all patient characteristics are entered, you will be asked to select the management option you currently plan. Once that information is entered, you can click the Submit Case button to view the experts’ recommendations.

After reviewing your case-specific recommendations, you will be asked brief questions about how the recommendations influenced your decision-making. You will then be able to enter a new case scenario by clicking the Start New Case button.

Additional sections appear in the table of contents menu that provide more information about this tool: About This Tool, Instructions, and Disclaimer.

When viewing the tool on the CCO Web site, you will also have the following options:

  • Print/download the recommendations along with a summary of the patient characteristics and selected therapy you entered by clicking the Case Summary button
  • Claim CME/CE credit for each case activity by answering the Clinical Implications questions and then clicking the Claim Credit button

Disclaimer: Access to and use of this Interactive Decision Support Tool titled, “Choosing Among GLP-1 Receptor Agonists for Patients With Type 2 Diabetes is provided subject to the following terms and conditions. PLEASE READ THESE TERMS CAREFULLY.

This Interactive Decision Support Tool is designed to educate clinicians on making optimal management choices when selecting among GLP-1 RAs. The information provided is based on expert guidance of Martin J. Abrahamson, MD, FACP; Zachary T. Bloomgarden, MD, MACE; Anne Peters, MD; Richard E. Pratley, MD; and Robert Zimmerman, MD.

The material published by Clinical Care Options reflects the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Although the information contained in the “Choosing Among GLP-1 Receptor Agonists for Patients With Type 2 Diabetes” Interactive Decision Support Tool has been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding the accuracy, adequacy, completeness, legality, reliability, or usefulness of any information. This disclaimer applies to both the isolated and aggregate uses of the information. Clinical Care Options provides this information on an as-is basis. This disclaimer applies to all material published by Clinical Care Options including but not limited to medical information or opinions. All warranties of any kind, expressed or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses, and noninfringement of proprietary rights are disclaimed.

Any trademarks are the property of respective companies.

© 2020 Clinical Care Options, LLC. All rights reserved.

Program Content